AstraZeneca to lower cost of medicines for American patients
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Investment to expand manufacturing and global medicine supply capacity
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Takeda will seek an external partner to leverage its cell therapy platform technologies
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Subscribe To Our Newsletter & Stay Updated